RAB4A and cancer: In this current study, we provide direct evidence, using both RAB4A-high and RAB4A-low cancer cell lines of diverse tissue origin, to demonstrate that suppressing RAB4A reduces the oncogenic potential in RAB4A-high cells, and that increasing the level of RAB4A promotes oncogenic potential in RAB4A-low cells.